Early diagnosis of thyrotoxic periodic paralysis: Spot urine calcium to phosphate ratio

Shih H. Lin, Pauling Chu, Chih J. Cheng, Shi J. Chu, Yi J. Hung, Yuh Feng Lin

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

OBJECTIVES: To identify a clinically reliable index of thyrotoxic periodic paralysis (TPP), a life-threatening emergency with unique and effective therapies. DESIGN: Diagnostic study. SETTING: University teaching hospital. PATIENTS: Fifty-three consecutive patients with hypokalemic paralysis during a 3-yr period and 30 thyrotoxic patients without paralysis as the thyrotoxic control group. INTERVENTIONS: For patients with hypokalemic paralysis, blood and second-void spot urine samples were obtained and measured by routine laboratory prior to therapy. For the thyrotoxic control group, blood and spot urine were collected when they visited outpatient clinics. MEASUREMENTS AND MAIN RESULTS: Twenty-nine patients fulfilled the criteria for TPP. Compared with the thyrotoxic control group, the TPP group had significant decreases in plasma potassium (K) and phosphate concentrations associated with very low urine K and phosphate excretion. Compared with the non-TPP group, the TPP group had significantly lower plasma creatinine and phosphate levels, a significantly higher urine calcium to creatinine ratio (0.25 ± 0.12 vs. 0.08 ± 0.07 mg/mg, p <.001), and a significantly lower urine phosphate to creatinine ratio (0.08 ± 0.05 vs. 0.31 ± 0.23 mg/mg, p <.001). The urine calcium to phosphate ratio had greater discriminatory power between TPP and non-TPP hypokalemic paralysis (4.1 ± 2.3 vs. 0.5 ± 0.6 mg/mg, p <.001). Using a urine calcium to phosphate ratio cutoff value of 1.7 mg/mg, sensitivity and specificity for TPP were 100% and 96%, respectively. CONCLUSIONS: Hypercalciuria and hypophosphaturia are characteristic features of TPP.

Original languageEnglish
Pages (from-to)2984-2989
Number of pages6
JournalCritical Care Medicine
Volume34
Issue number12
DOIs
Publication statusPublished - Dec 2006
Externally publishedYes

Fingerprint

Paralysis
Early Diagnosis
Urine
Creatinine
Phosphates
Control Groups
calcium phosphate
Hypokalemic Periodic Paralysis
Hypercalciuria
Ambulatory Care Facilities
Teaching Hospitals
Emergencies
Calcium
Sensitivity and Specificity

Keywords

  • Hyperthyroidism
  • Hypokalemia
  • Hypophosphatemia
  • Paralysis
  • Urine calcium
  • Urine phosphate

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Early diagnosis of thyrotoxic periodic paralysis : Spot urine calcium to phosphate ratio. / Lin, Shih H.; Chu, Pauling; Cheng, Chih J.; Chu, Shi J.; Hung, Yi J.; Lin, Yuh Feng.

In: Critical Care Medicine, Vol. 34, No. 12, 12.2006, p. 2984-2989.

Research output: Contribution to journalArticle

Lin, Shih H. ; Chu, Pauling ; Cheng, Chih J. ; Chu, Shi J. ; Hung, Yi J. ; Lin, Yuh Feng. / Early diagnosis of thyrotoxic periodic paralysis : Spot urine calcium to phosphate ratio. In: Critical Care Medicine. 2006 ; Vol. 34, No. 12. pp. 2984-2989.
@article{e1f3608945fc40ac9f0c4a3efe7d0e27,
title = "Early diagnosis of thyrotoxic periodic paralysis: Spot urine calcium to phosphate ratio",
abstract = "OBJECTIVES: To identify a clinically reliable index of thyrotoxic periodic paralysis (TPP), a life-threatening emergency with unique and effective therapies. DESIGN: Diagnostic study. SETTING: University teaching hospital. PATIENTS: Fifty-three consecutive patients with hypokalemic paralysis during a 3-yr period and 30 thyrotoxic patients without paralysis as the thyrotoxic control group. INTERVENTIONS: For patients with hypokalemic paralysis, blood and second-void spot urine samples were obtained and measured by routine laboratory prior to therapy. For the thyrotoxic control group, blood and spot urine were collected when they visited outpatient clinics. MEASUREMENTS AND MAIN RESULTS: Twenty-nine patients fulfilled the criteria for TPP. Compared with the thyrotoxic control group, the TPP group had significant decreases in plasma potassium (K) and phosphate concentrations associated with very low urine K and phosphate excretion. Compared with the non-TPP group, the TPP group had significantly lower plasma creatinine and phosphate levels, a significantly higher urine calcium to creatinine ratio (0.25 ± 0.12 vs. 0.08 ± 0.07 mg/mg, p <.001), and a significantly lower urine phosphate to creatinine ratio (0.08 ± 0.05 vs. 0.31 ± 0.23 mg/mg, p <.001). The urine calcium to phosphate ratio had greater discriminatory power between TPP and non-TPP hypokalemic paralysis (4.1 ± 2.3 vs. 0.5 ± 0.6 mg/mg, p <.001). Using a urine calcium to phosphate ratio cutoff value of 1.7 mg/mg, sensitivity and specificity for TPP were 100{\%} and 96{\%}, respectively. CONCLUSIONS: Hypercalciuria and hypophosphaturia are characteristic features of TPP.",
keywords = "Hyperthyroidism, Hypokalemia, Hypophosphatemia, Paralysis, Urine calcium, Urine phosphate",
author = "Lin, {Shih H.} and Pauling Chu and Cheng, {Chih J.} and Chu, {Shi J.} and Hung, {Yi J.} and Lin, {Yuh Feng}",
year = "2006",
month = "12",
doi = "10.1097/01.CCM.0000242249.10856.49",
language = "English",
volume = "34",
pages = "2984--2989",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Early diagnosis of thyrotoxic periodic paralysis

T2 - Spot urine calcium to phosphate ratio

AU - Lin, Shih H.

AU - Chu, Pauling

AU - Cheng, Chih J.

AU - Chu, Shi J.

AU - Hung, Yi J.

AU - Lin, Yuh Feng

PY - 2006/12

Y1 - 2006/12

N2 - OBJECTIVES: To identify a clinically reliable index of thyrotoxic periodic paralysis (TPP), a life-threatening emergency with unique and effective therapies. DESIGN: Diagnostic study. SETTING: University teaching hospital. PATIENTS: Fifty-three consecutive patients with hypokalemic paralysis during a 3-yr period and 30 thyrotoxic patients without paralysis as the thyrotoxic control group. INTERVENTIONS: For patients with hypokalemic paralysis, blood and second-void spot urine samples were obtained and measured by routine laboratory prior to therapy. For the thyrotoxic control group, blood and spot urine were collected when they visited outpatient clinics. MEASUREMENTS AND MAIN RESULTS: Twenty-nine patients fulfilled the criteria for TPP. Compared with the thyrotoxic control group, the TPP group had significant decreases in plasma potassium (K) and phosphate concentrations associated with very low urine K and phosphate excretion. Compared with the non-TPP group, the TPP group had significantly lower plasma creatinine and phosphate levels, a significantly higher urine calcium to creatinine ratio (0.25 ± 0.12 vs. 0.08 ± 0.07 mg/mg, p <.001), and a significantly lower urine phosphate to creatinine ratio (0.08 ± 0.05 vs. 0.31 ± 0.23 mg/mg, p <.001). The urine calcium to phosphate ratio had greater discriminatory power between TPP and non-TPP hypokalemic paralysis (4.1 ± 2.3 vs. 0.5 ± 0.6 mg/mg, p <.001). Using a urine calcium to phosphate ratio cutoff value of 1.7 mg/mg, sensitivity and specificity for TPP were 100% and 96%, respectively. CONCLUSIONS: Hypercalciuria and hypophosphaturia are characteristic features of TPP.

AB - OBJECTIVES: To identify a clinically reliable index of thyrotoxic periodic paralysis (TPP), a life-threatening emergency with unique and effective therapies. DESIGN: Diagnostic study. SETTING: University teaching hospital. PATIENTS: Fifty-three consecutive patients with hypokalemic paralysis during a 3-yr period and 30 thyrotoxic patients without paralysis as the thyrotoxic control group. INTERVENTIONS: For patients with hypokalemic paralysis, blood and second-void spot urine samples were obtained and measured by routine laboratory prior to therapy. For the thyrotoxic control group, blood and spot urine were collected when they visited outpatient clinics. MEASUREMENTS AND MAIN RESULTS: Twenty-nine patients fulfilled the criteria for TPP. Compared with the thyrotoxic control group, the TPP group had significant decreases in plasma potassium (K) and phosphate concentrations associated with very low urine K and phosphate excretion. Compared with the non-TPP group, the TPP group had significantly lower plasma creatinine and phosphate levels, a significantly higher urine calcium to creatinine ratio (0.25 ± 0.12 vs. 0.08 ± 0.07 mg/mg, p <.001), and a significantly lower urine phosphate to creatinine ratio (0.08 ± 0.05 vs. 0.31 ± 0.23 mg/mg, p <.001). The urine calcium to phosphate ratio had greater discriminatory power between TPP and non-TPP hypokalemic paralysis (4.1 ± 2.3 vs. 0.5 ± 0.6 mg/mg, p <.001). Using a urine calcium to phosphate ratio cutoff value of 1.7 mg/mg, sensitivity and specificity for TPP were 100% and 96%, respectively. CONCLUSIONS: Hypercalciuria and hypophosphaturia are characteristic features of TPP.

KW - Hyperthyroidism

KW - Hypokalemia

KW - Hypophosphatemia

KW - Paralysis

KW - Urine calcium

KW - Urine phosphate

UR - http://www.scopus.com/inward/record.url?scp=33751339775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751339775&partnerID=8YFLogxK

U2 - 10.1097/01.CCM.0000242249.10856.49

DO - 10.1097/01.CCM.0000242249.10856.49

M3 - Article

C2 - 16971853

AN - SCOPUS:33751339775

VL - 34

SP - 2984

EP - 2989

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 12

ER -